| REGISTERED NUMBER: |
| Unaudited Financial Statements for the Year Ended 31 December 2024 |
| for |
| Halcyon Doctors Limited |
| REGISTERED NUMBER: |
| Unaudited Financial Statements for the Year Ended 31 December 2024 |
| for |
| Halcyon Doctors Limited |
| Halcyon Doctors Limited (Registered number: 07828427) |
| Contents of the Financial Statements |
| for the Year Ended 31 December 2024 |
| Page |
| Company Information | 1 |
| Balance Sheet | 2 |
| Notes to the Financial Statements | 3 |
| Halcyon Doctors Limited |
| Company Information |
| for the Year Ended 31 December 2024 |
| DIRECTORS: |
| REGISTERED OFFICE: |
| REGISTERED NUMBER: |
| Halcyon Doctors Limited (Registered number: 07828427) |
| Balance Sheet |
| 31 December 2024 |
| 2024 | 2023 |
| Notes | £ | £ |
| CURRENT ASSETS |
| Debtors | 4 |
| Cash at bank |
| CREDITORS |
| Amounts falling due within one year | 5 | ( |
) | ( |
) |
| NET CURRENT ASSETS |
| TOTAL ASSETS LESS CURRENT LIABILITIES |
| CREDITORS |
| Amounts falling due after more than one year |
6 |
( |
) |
( |
) |
| NET LIABILITIES | ( |
) | ( |
) |
| CAPITAL AND RESERVES |
| Called up share capital | 8 |
| Share premium |
| Retained earnings | ( |
) | ( |
) |
| SHAREHOLDERS' FUNDS | ( |
) | ( |
) |
| The directors acknowledge their responsibilities for: |
| (a) | ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and |
| (b) | preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company. |
| The financial statements were approved by the Board of Directors and authorised for issue on |
| Halcyon Doctors Limited (Registered number: 07828427) |
| Notes to the Financial Statements |
| for the Year Ended 31 December 2024 |
| 1. | STATUTORY INFORMATION |
| Halcyon Doctors Limited is a |
| 2. | ACCOUNTING POLICIES |
| Basis of preparing the financial statements |
| These financial statements have been prepared using the historical cost convention except that as |
| disclosed in the accounting policies certain items are shown at fair value. |
| The financial statements are prepared in sterling, which is the functional currency of the entity. |
| Statement of compliance |
| These financial statements have been prepared in accordance with Financial Reporting Standard 102 |
| Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and |
| Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small |
| companies' regime). |
| Judgements |
| The preparation of the financial statements requires management to make judgements, estimates and |
| assumptions that affect the amounts reported. These estimates and judgements are continually |
| reviewed and are based on experience and other factors, including expectations of future events that |
| are believed to be reasonable under the circumstances. |
| Going concern |
| The financial statements have been prepared on a going concern basis. The company has net current |
| liabilities and a negative balance sheet at the year end and has recorded a loss in the current year. |
| The Directors believe that the company is a going concern on the basis of its knowledge of future |
| income streams and cost base, on this basis the Directors consider it appropriate to prepare the |
| accounts on a going concern basis. |
| Taxation |
| Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Profit and Loss., except to the extent that it relates to items recognised in other comprehensive income or directly in equity. |
| Current or deferred taxation assets and liabilities are not discounted. |
| Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date. |
| Deferred tax |
| Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date. |
| Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference. |
| Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. |
| Pension costs and other post-retirement benefits |
| The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate. |
| Revenue recognition |
| The company recognises revenue when: |
| The amount of revenue can be reliably measured; |
| it is probable that future economic benefits will flow to the entity; |
| and specific criteria have been met for each of the company's activities. |
| Halcyon Doctors Limited (Registered number: 07828427) |
| Notes to the Financial Statements - continued |
| for the Year Ended 31 December 2024 |
| 2. | ACCOUNTING POLICIES - continued |
| Cash and cash equivalents |
| Cash and cash equivalents comprise cash on hand and call deposits. |
| Trade debtors |
| Trade debtors are amounts due from customers for merchandise sold or services performed in the |
| ordinary course of business. |
| Trade creditors |
| Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary |
| course of business from suppliers. Accounts payable are classified as current liabilities if the company |
| does not have an unconditional right, at the end of the reporting period, to defer settlement of the |
| creditor for at least twelve months after the reporting date. If there is an unconditional right to defer |
| settlement for at least twelve months after the reporting date, they are presented as non-current |
| liabilities. |
| Trade creditors are recognised at the transaction price. |
| Share capital |
| Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash |
| or other resources received or receivable, net of the direct costs of issuing the equity instruments. If |
| payment is deferred and the time value of money is material, the initial measurement is on a present |
| value basis. |
| Defined contribution pension obligation |
| A defined contribution plan is a pension plan under which fixed contributions are paid into a pension |
| fund and the company has no legal or constructive obligation to pay further contributions even if the |
| fund does not hold sufficient assets to pay all employees the benefits relating to employee service in |
| the current and prior periods. |
| Contributions to defined contribution plans are recognised as employee benefit expense when they |
| are due. If contribution payments exceed the contribution due for service, the excess is recognised as |
| a prepayment. |
| 3. | EMPLOYEES AND DIRECTORS |
| The average number of employees during the year was |
| 4. | DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |
| 2024 | 2023 |
| £ | £ |
| Trade debtors |
| Other debtors |
| 5. | CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |
| 2024 | 2023 |
| £ | £ |
| Trade creditors |
| Taxation and social security |
| Other creditors |
| 6. | CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR |
| 2024 | 2023 |
| £ | £ |
| Other creditors |
| Halcyon Doctors Limited (Registered number: 07828427) |
| Notes to the Financial Statements - continued |
| for the Year Ended 31 December 2024 |
| 6. | CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR - continued |
| 2024 | 2023 |
| £ | £ |
| Amounts falling due in more than five years: |
| Repayable by instalments |
| Other loans more 5yrs instal | 1,322,017 | 1,317,372 |
| 7. | LOANS |
| An analysis of the maturity of loans is given below: |
| 2024 | 2023 |
| £ | £ |
| Amounts falling due within one year or on demand: |
| Other loans |
| Amounts falling due in more than five years: |
| Repayable by instalments |
| Other loans more 5yrs instal | 1,322,017 | 1,317,372 |
| 8. | CALLED UP SHARE CAPITAL |
| Allotted, issued and fully paid: |
| Number: | Class: | Nominal | 2024 | 2023 |
| value: | £ | £ |
| A Ordinary | 0.01 | 13,411 | 13,411 |
| C Ordinary | 0.01 | 1,937 | 1,937 |
| 15,348 | 15,348 |
| 9. | RELATED PARTY DISCLOSURES |
| At the balance sheet date D Gunasinghe owed £300 (2023: £300), R Van Den Brink owed £1200 |
| (2023: £1200) and J Warner owed £100 (2023: £100) for unpaid share capital, all Directors of the |
| company. At the balance sheet date the company owed R Van Den Brink £84,008 (2023: £80,777), |
| there are no terms for repayment and interest is charged at 4% per annum. |
| The unsecured loans are from relations of the Directors. There are no formal terms for repayment and |
| interest is being charged at 4% per annum. |